By PHC Europe…
To get in touch with PHC Europe B.V. Supports Cancer Research, simply fill out the form below.
Subscribe to Supplier
PHC Europe B.V. Supports Cancer Research
Cancer affects us all. One in three Dutch people will develop cancer during their lifetime, which amounts to more than 100,000 people each year. That’s 12 people per hour … which, of course, is way too many. Each year, nearly 42,000 people die of cancer, making this disease the leading cause of death in the Netherlands. So PHC Europe B.V. is helping to build a better future, as one of the Business Friends of the Dutch Cancer Society (KWF Kankerbestrijding).
Together with millions of people, PHC Europe B.V. shares the dream of a world in which cancer is no longer a fatal disease. Wouldn’t it be wonderful if this dream were to come true? This is why PHC Europe B.V. has chosen to be a Business Friend of the Dutch Cancer Society – to help make this happen.
Scientists throughout the world are doing their utmost to bring about the dawn of an era in which cancer is no longer a fatal disease. They are working as fast as they can. As fast as the available resources allow them. Research improves the prospects for existing cancer patients, while reducing people’s risk of getting cancer in the first place.
Business Friend of the Dutch Cancer Society As a Business Friend of the Dutch Cancer Society, PHC Europe B.V. supports cancer research. It contributes a fixed monthly amount towards research and towards the development of Dutch Cancer Society fellows. This helps talented young researchers to gain experience in scientific cancer research and/or in the specialist treatment of cancer. These leading lights in cancer research are a particularly good investment, as many former fellows now occupy top positions in this field.
Help us build a better future Would you be interested in learning more about the Business Friend of the Dutch Cancer Society program, or about cancer research? If so, please visit the Dutch Cancer Society’s website: www.kwf.nl/zakenvrienden
Netherlands-based PHC Europe BV (PHCEU) is the European and African arm of the international PHC Corporation, whose PHCbi products are recognized worldwide as a leading and trusted brand for reliable, high-quality medical and laboratory equipment, with particular focus on technologies for preservation, incubation, sterilization and healthcare.
The company’s mission is to provide a leading, trusted brand for sustainable healthcare and biomedical product solutions, supporting the work of its customers to improve the health and well-being of people around the world.
PHCEU solutions range from excellent sample security in an ultra-low temperature (ULT) freezer or the best environment for cell culture in a CO2 incubator, while its relationships span the pharmaceutical, healthcare and biotechnology sectors, with a pan-continental supply and support network that can quickly meet customer demands across Europe and Africa.
PHCbi products are grouped in four main ranges: Preservation, Incubation, Processing and Sterilization and include ULT, cryogenic and biomedical Freezers, pharmaceutical and blood bank refrigerators, liquid nitrogen cryopreservation freezers, lab tanks, transport containers and vapor shippers and a range of incubation and sterilization solutions.
PHCEU is part of the international PHC Corporation, founded in Japan in 1969, that now operates across more than 120 countries worldwide, focusing on the three core business fields of Medical Devices, Healthcare IT & Life Sciences.
PHC products and facilities are certified to ISO 9001, ISO 14001 and ISO 13485 standards for quality, environmental management and medical devices.
PHC can provide turnkey solutions for validation and qualification in accordance with all current GMPs, GLPs, GCPs, 21 CFR Part 11, PAT, ISO and specific customer requirements and applications.